I n a challenging year for Moringa Acquisition Corp (SLXN), the company's stock has plummeted to a 52-week low, trading at $0.79, with a market capitalization of just $1.29 million. InvestingPro ...

Shares fell over 13% premarket Wednesday. Silexion Therapeutics (SLXN) The cancer-focused biotech firm’s ticker saw a 9,060% surge in retail message volume as its stock more than doubled Tuesday ...

Shares of Silexion Therapeutics Corp (NASDAQ:SLXN – Get Free Report) shot up 46.5% during mid-day trading on Wednesday .The company traded as high as $1.29 and last traded at $1.03. 66,915,194 ...

Silexion Therapeutics (SLXN) announced a strategic collaboration with Catalent (CTLT). Under the agreement, Catalent will conduct formulation development and clinical manufacturing activities for ...

(RTTNews) - Silexion Therapeutics Corp. (SLXN) on Wednesday announced a strategic collaboration with Catalent Inc., a global contract development and manufacturing organization, for its SIL204 ...

Silexion Therapeutics (SLXN) announced it has completed an expanded development plan for its next-generation siRNA candidate, SIL204, which the company’s management will be presenting at the ...

Short interest in Silexion Therapeutics Corp (NASDAQ:SLXN) decreased during the last reporting period, falling from 976.48K to 424.33K. This put 5.17% of the company's publicly available shares short.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...